D.A. Davidson & CO. Lowers Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

D.A. Davidson & CO. lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 27.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,192 shares of the biotechnology company’s stock after selling 3,430 shares during the period. D.A. Davidson & CO.’s holdings in Axon Enterprise were worth $5,463,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in AXON. Prestige Wealth Management Group LLC raised its holdings in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at about $40,000. Brooklyn Investment Group purchased a new stake in shares of Axon Enterprise in the third quarter valued at about $41,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at about $45,000. Finally, Planning Capital Management Corp increased its holdings in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,711 shares of company stock valued at $5,631,561 in the last quarter. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $593.42 on Thursday. Axon Enterprise, Inc. has a fifty-two week low of $260.27 and a fifty-two week high of $715.99. The business has a 50-day simple moving average of $624.50 and a two-hundred day simple moving average of $515.36. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $45.25 billion, a price-to-earnings ratio of 153.34, a price-to-earnings-growth ratio of 6.85 and a beta of 1.05.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. JMP Securities raised their price objective on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 4th. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Two research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.